Literature DB >> 15181011

Transcriptional repressor DREAM interacts with thyroid transcription factor-1 and regulates thyroglobulin gene expression.

Marcos Rivas1, Britt Mellström, José R Naranjo, Pilar Santisteban.   

Abstract

Tissue-specific gene expression depends on the interaction between tissue-specific and general transcription factors. DREAM is a Ca2+-dependent transcriptional repressor widely expressed in the brain where it participates in nociception through its control of prodynorphin gene expression. In the periphery, DREAM is highly expressed in the thyroid gland, the immune system, and the reproductive organs. Here, we show that DREAM interacts with thyroid-specific transcription factor TTF-1 and regulates the expression of the thyroglobulin (Tg) gene. The mechanism also involves binding of DREAM to the thyroglobulin promoter and blockage of TTF-1-mediated transactivation. The TSH/cAMP pathway and Ca2+ signaling regulate DREAM-mediated transcriptional repression of the thyroglobulin gene. Furthermore, chromatin immunoprecipitation experiments in FRTL-5 cells confirmed that Tg is a bona fide target gene for DREAM transrepression in thyroid follicular cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15181011     DOI: 10.1074/jbc.M403526200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  Modulation of human Kv4.3/KChIP2 channel inactivation kinetics by cytoplasmic Ca2.

Authors:  Christiane Groen; Robert Bähring
Journal:  Pflugers Arch       Date:  2017-07-22       Impact factor: 3.657

2.  Ca2+-calmodulin-dependent protein kinase II represses cardiac transcription of the L-type calcium channel alpha(1C)-subunit gene (Cacna1c) by DREAM translocation.

Authors:  Jarkko J Ronkainen; Sandra L Hänninen; Topi Korhonen; Jussi T Koivumäki; Reka Skoumal; Sini Rautio; Veli-Pekka Ronkainen; Pasi Tavi
Journal:  J Physiol       Date:  2011-03-28       Impact factor: 5.182

3.  Calcium influx and DREAM protein are required for GnRH gene expression pulse activity.

Authors:  Gilles M Leclerc; Fredric R Boockfor
Journal:  Mol Cell Endocrinol       Date:  2006-12-27       Impact factor: 4.102

4.  Transcriptional repressor DREAM regulates T-lymphocyte proliferation and cytokine gene expression.

Authors:  Magali Savignac; Belen Pintado; Alfonso Gutierrez-Adan; Malgorzata Palczewska; Britt Mellström; Jose R Naranjo
Journal:  EMBO J       Date:  2005-09-22       Impact factor: 11.598

5.  HDAC4 and HDAC5 form a complex with DREAM that epigenetically down-regulates NCX3 gene and its pharmacological inhibition reduces neuronal stroke damage.

Authors:  Luigi Formisano; Giusy Laudati; Natascia Guida; Luigi Mascolo; Angelo Serani; Ornella Cuomo; Maria Cantile; Francesca Boscia; Pasquale Molinaro; Serenella Anzilotti; Vincenzo Pizzorusso; Gianfranco Di Renzo; Giuseppe Pignataro; Lucio Annunziato
Journal:  J Cereb Blood Flow Metab       Date:  2019-11-07       Impact factor: 6.200

Review 6.  PACAP signaling to DREAM: a cAMP-dependent pathway that regulates cortical astrogliogenesis.

Authors:  Mario Vallejo
Journal:  Mol Neurobiol       Date:  2009-02-24       Impact factor: 5.590

7.  The DREAM protein is associated with thyroid enlargement and nodular development.

Authors:  Marcos Rivas; Britt Mellström; Begoña Torres; Gaetano Cali; Alfonso M Ferrara; Daniela Terracciano; Mariastella Zannini; Gabriella Morreale de Escobar; Jose R Naranjo
Journal:  Mol Endocrinol       Date:  2009-03-19

Review 8.  Visinin-like proteins (VSNLs): interaction partners and emerging functions in signal transduction of a subfamily of neuronal Ca2+ -sensor proteins.

Authors:  Karl-Heinz Braunewell; Andres J Klein-Szanto; Andres J Klein Szanto
Journal:  Cell Tissue Res       Date:  2008-11-07       Impact factor: 5.249

9.  DREAM controls the on/off switch of specific activity-dependent transcription pathways.

Authors:  Britt Mellström; Ignasi Sahún; Ana Ruiz-Nuño; Patricia Murtra; Rosa Gomez-Villafuertes; Magali Savignac; Juan C Oliveros; Paz Gonzalez; Asta Kastanauskaite; Shira Knafo; Min Zhuo; Alejandro Higuera-Matas; Michael L Errington; Rafael Maldonado; Javier DeFelipe; John G R Jefferys; Tim V P Bliss; Mara Dierssen; Jose R Naranjo
Journal:  Mol Cell Biol       Date:  2013-12-23       Impact factor: 4.272

10.  The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors.

Authors:  Iñigo Landa; Sergio Ruiz-Llorente; Cristina Montero-Conde; Lucía Inglada-Pérez; Francesca Schiavi; Susanna Leskelä; Guillermo Pita; Roger Milne; Javier Maravall; Ignacio Ramos; Víctor Andía; Paloma Rodríguez-Poyo; Antonino Jara-Albarrán; Amparo Meoro; Cristina del Peso; Luis Arribas; Pedro Iglesias; Javier Caballero; Joaquín Serrano; Antonio Picó; Francisco Pomares; Gabriel Giménez; Pedro López-Mondéjar; Roberto Castello; Isabella Merante-Boschin; Maria-Rosa Pelizzo; Didac Mauricio; Giuseppe Opocher; Cristina Rodríguez-Antona; Anna González-Neira; Xavier Matías-Guiu; Pilar Santisteban; Mercedes Robledo
Journal:  PLoS Genet       Date:  2009-09-04       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.